Gloria R. Boyland bought $5,379 of VNT
director at Vontier Corp. 300 shares at an average of $17.93, traded Nov 7, 2022, filed Jan 8, 2024.
Score components
- +15RoleDirector
- 0Trade size$5k at market
- 0Relative to holdingsHoldings up 1.0%
- +8Price context45% below the 52-week high
- 0ClusterNo other insider buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001786842-24-000003, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Nov 7, 2022 | POpen-market purchase Common Stock, par value $0.0001 | +300 | $17.93 | $5,379 | 29,150 | Jan 8, 2024 |
Related signals
Other insiders at Vontier Corp and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 22Weak | Vontier Corp | Anshooman Aga EVP, Chief Financial Officer | $220k 5,489 shares | -4% | |
| 45Moderate | Vontier Corp | Kathryn K. Rowen EVP Chief Transf. & Op Officer | $468k 11,264 shares | -10% | |
| 28Weak | VNTsell Vontier Corp | Kathryn K. Rowen SVP, Chief Admin. Officer | $267k 7,344 shares | -8% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.